Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 13, Issue 4, 1994, Pages 347-351

  Presterl, E ^a   Graninger, W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; LIVER ENZYME;

ADOLESCENT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CHILD; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EOSINOPHIL; FEMALE; FUNGEMIA; HEARING IMPAIRMENT; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; ORAL DRUG ADMINISTRATION; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC MYCOSIS; VOMITING;

ADOLESCENT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMAN; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS;

EID: 0028222208     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01974618     Document Type: Article

References (23)

1. Systemic candidiasis: a study with 109 fatal cases
2. Candida sepsis in very low birthweight infants
3. Pharmacokinetic evaluation of UK-49,858, a metabolically stable antifungal drug, in animals and humans
4. Impact of the changing epidemiology of fungal infections in the 1990s
5. Fungal infections in cancer patients: an international autopsy survey
6. The use of amphotericin B in nosocomial fungal infections
7. Amphotericin B-induced nephrotoxicity decreased by sodium loading
8. Amphotericin B: delivery systems
9. New methods of delivery of amphotericin B
10. Liposomal amphotericin B in a 9-month old liver recipient
11. Liposomal amphotericin B
12. Liposomal amphotericin B (AmBisome) for the treatment of disseminated fungal infections in two infants of very low birth weight
13. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses
14. Efficacy of fluconazole in the treatment of systemic fungal infections
15. Fluconazole in the treatment of candidiasis in immunocompromised children
16. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
17. Fluconazole resistance in Candida glabrata
18. Fluconazole failure in the treatment of invasive mycoses
19. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents
20. Antifungal susceptibility tests
21. Failure of fluconazole in systemic candidiasis
22. Treatment of Candida albicans fungemia with fluconazole
23. A clinical study of fluconazole in the treatment of deep mycoses